1.17. Analysis.
Comparison 1: Higher‐dose anticoagulants versus lower‐dose anticoagulants (short term), Outcome 17: Adverse events (myocardial infarction) ‐ trials at low risk of bias
Comparison 1: Higher‐dose anticoagulants versus lower‐dose anticoagulants (short term), Outcome 17: Adverse events (myocardial infarction) ‐ trials at low risk of bias